scholarly article | Q13442814 |
P356 | DOI | 10.1093/AJE/KWR439 |
P8608 | Fatcat ID | release_dla6c2m6jzdjlhgobvhomivqdi |
P932 | PMC publication ID | 3271817 |
P698 | PubMed publication ID | 22247047 |
P5875 | ResearchGate publication ID | 221749329 |
P50 | author | Donna Baird | Q97362625 |
P2093 | author name string | Anne Z Steiner | |
P2860 | cites work | Antimüllerian hormone as a predictor of natural fecundability in women aged 30-42 years | Q23910016 |
Prospective assessment of fecundability of female semiconductor workers | Q23910490 | ||
Reducing unintended pregnancy in the United States | Q28261251 | ||
The impact of smoking on antimüllerian hormone levels in women aged 38 to 50 years | Q28395441 | ||
The LIFESTYLE study: costs and effects of a structured lifestyle program in overweight and obese subfertile women to reduce the need for fertility treatment and improve reproductive outcome. A randomised controlled trial | Q33616835 | ||
Reporting errors in time-to-pregnancy data collected with a short questionnaire. Impact on power and estimation of fecundability ratios | Q33634977 | ||
Oestrogen treatment to reduce the adult height of tall girls: long-term effects on fertility. | Q33982538 | ||
Anti-mullerian hormone predicts menopause: a long-term follow-up study in normoovulatory women | Q34187352 | ||
Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study | Q34410229 | ||
Validity of self-reported time to pregnancy | Q34485478 | ||
Variations in serum müllerian inhibiting substance between white, black, and Hispanic women. | Q34568747 | ||
Relating smoking, obesity, insulin resistance, and ovarian biomarker changes to the final menstrual period | Q35811703 | ||
Environmental and occupational factors affecting fertility and IVF success | Q35985646 | ||
Design and analysis of time-to-pregnancy | Q36449447 | ||
Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition | Q36938334 | ||
An internet-based prospective study of body size and time-to-pregnancy. | Q37479057 | ||
Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). | Q37606149 | ||
The adverse effects of obesity on conception and implantation | Q37731767 | ||
The journey from the old to the new AMH assay: how to avoid getting lost in the values | Q37923047 | ||
Infertility among women exposed prenatally to diethylstilbestrol. | Q38456599 | ||
Pretreatment serum anti-müllerian hormone predicts long-term ovarian function and bone mass after chemotherapy for early breast cancer | Q39782486 | ||
Tobacco use, alcohol consumption and infertility | Q40273246 | ||
Cigarette smoking associated with delayed conception | Q41498815 | ||
Anti-Müllerian hormone follow-up in young women treated by chemotherapy for lymphoma: preliminary results. | Q43180203 | ||
Antimüllerian hormone serum levels: a putative marker for ovarian aging | Q43872554 | ||
The Dalkon Shield saga | Q43935887 | ||
Use of time to pregnancy to study environmental exposures | Q44549160 | ||
Anti-Müllerian hormone concentrations in maternal serum during pregnancy. | Q45285273 | ||
Prolonged time to pregnancy in residents exposed to ionising radiation in cobalt-60-contaminated buildings. | Q45866891 | ||
Serum antimüllerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids | Q46963807 | ||
The risk of infertility and delayed conception associated with exposures in the Danish workplace. | Q50554414 | ||
Mullerian inhibiting substance in humans: normal levels from infancy to adulthood. | Q51032507 | ||
Serum anti-Mullerian hormone throughout the human menstrual cycle. | Q51789873 | ||
Anti-Müllerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation. | Q51798174 | ||
Using infertile patients in epidemiologic studies on subfecundity and embryonal loss. | Q52040935 | ||
Sources of bias in studies of time to pregnancy. | Q52882278 | ||
Feasibility of the current-duration approach to studying human fecundity. | Q53004929 | ||
Serum Levels of Anti-Müllerian Hormone as a Marker of Ovarian Function in 926 Healthy Females from Birth to Adulthood and in 172 Turner Syndrome Patients | Q57402015 | ||
Validity Issues Relating to Time-to-Pregnancy Studies of Fertility | Q57420041 | ||
Has Human Fertility Declined Over Time? | Q57420044 | ||
The reproducibility of serum anti-Müllerian hormone in subfertile women: within and between patient variability | Q58376346 | ||
Longitudinal assessment of antimüllerian hormone during pregnancy—relationship with maternal adiposity, insulin, and adiponectin | Q61847480 | ||
Prolonged Time to Pregnancy in Female Workers Exposed to Ethylene Glycol Ethers in Semiconductor Manufacturing | Q61851069 | ||
Primary tubal infertility in relation to the use of an intrauterine device | Q70063811 | ||
Tubal infertility and the intrauterine device | Q70063814 | ||
The relation of obesity to menstrual disturbances | Q76190398 | ||
Validity of self-reported time to pregnancy | Q82241954 | ||
Age-specific serum anti-Müllerian hormone values for 17,120 women presenting to fertility centers within the United States | Q82444629 | ||
Heterogeneity in fecundability studies: issues and modelling | Q83156642 | ||
Fertility and ovarian function in high-dose estrogen-treated tall women | Q83356669 | ||
Antimüllerian hormone and polycystic ovary syndrome | Q84056753 | ||
Correlation of ovarian reserve tests with histologically determined primordial follicle number | Q84351138 | ||
Development of a second generation anti-Müllerian hormone (AMH) ELISA | Q84963686 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 245-249 | |
P577 | publication date | 2012-01-12 | |
P1433 | published in | American Journal of Epidemiology | Q4744243 |
P1476 | title | Anti-Müllerian hormone: a potential new tool in epidemiologic studies of female fecundability | |
P478 | volume | 175 |
Q33924350 | Active and passive smoking and fecundability in Danish pregnancy planners |
Q28394989 | Alcohol, cigarette smoking, and ovarian reserve in reproductive-age African-American women |
Q58352100 | Anti-Mullerian hormone and risk of invasive serous ovarian cancer |
Q35269307 | Anti-Müllerian hormone and lifestyle, reproductive, and environmental factors among women in rural South Africa |
Q51127348 | Anti-Müllerian hormone as a possible predictor of fecundability in subfertile women over 38 years: a retrospective cohort study. |
Q64126132 | Anti-Müllerian hormone levels in nurses working night shifts |
Q35890023 | Anti-mullerian hormone (AMH) is associated with natural menopause in a population-based sample: The CARDIA Women's Study. |
Q98946602 | Association between a history of depression and anti-müllerian hormone among late-reproductive aged women: the Harvard study of moods and cycles |
Q28387318 | Association between serum 25-hydroxyvitamin D and ovarian reserve in premenopausal women |
Q46065513 | Best Practices in Counseling Young Female Cancer Survivors on Reproductive Health |
Q40375111 | Cross-sectional study of the ultrasonographic and hormonal characteristics of obstetric fistula patients with and without secondary amenorrhea |
Q50047483 | Evaluating the effects of administration of 25-hydroxyvitamin D supplement on serum anti-mullerian hormone (AMH) levels in infertile women |
Q93335254 | Oncofertility: Meeting the Fertility Goals of Adolescents and Young Adults With Cancer |
Q89980600 | Parameters of ovarian reserve in relation to urinary concentrations of parabens |
Q37512512 | Possible role of autoimmunity in patients with premature ovarian insufficiency |
Q48141819 | The Fertility Assessment and Counseling Clinic - does the concept work? A prospective 2-year follow-up study of 519 women |
Q28278102 | The ageing ovary and uterus: new biological insights |
Q48567619 | The influence of AMH on IVF success |
Search more.